Clinical Report: The Relationship Between Anemia and Blood Biomarkers in Alzheimer’s Disease

Overview

This study investigates the association between anemia and Alzheimer’s disease (AD) blood biomarkers in older adults. Findings suggest that lower hemoglobin levels may correlate with increased dementia risk and alterations in AD biomarkers, potentially indicating underlying neuropathology.

Background

Anemia is prevalent in older adults and has been linked to adverse health outcomes, including increased dementia risk. Understanding the relationship between anemia and cognitive decline is crucial, as it may reveal mechanisms contributing to neurodegeneration. Blood biomarkers for AD provide a promising avenue for exploring these associations and enhancing our understanding of dementia development.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

• Anemia affects approximately 10% of individuals aged 65 years and older in the US.
• Chronic cerebral hypoxia and oxidative stress from anemia may contribute to neuronal loss and vascular dysfunction.
• Blood biomarkers like p-tau217, NfL, and GFAP reflect early pathologic changes in cognitively unimpaired individuals.
• Individuals with anemia exhibited elevated levels of several AD blood biomarkers in previous studies.
• The study utilized data from over 2000 older adults in the Swedish National Study on Aging and Care in Kungsholmen (SNAC-K).

Clinical Implications

Clinicians should consider the potential impact of anemia on cognitive health in older adults. Monitoring hemoglobin levels and associated blood biomarkers may provide insights into dementia risk and underlying neuropathology.

Conclusion

The interplay between anemia and AD blood biomarkers warrants further investigation to clarify its role in dementia development. Understanding this relationship could enhance early detection and intervention strategies for at-risk populations.

Related Resources & Content

1. Retinal Physician, Retinal Physician, 2024 -- Retinal Biomarkers for Alzheimer Disease
2. Brain, Brain, 2024 -- Exploring the Relationship Between Mild Behavioral Impairment-Apathy and Key Alzheimer's Disease Cerebrospinal Fluid Biomarkers
3. Acta Neuropathologica, Acta Neuropathologica, 2022 -- Plasma Biomarkers Associated with Alzheimer’s Disease: Links to Neuropathological Changes and Cognitive Decline
4. Brain, Brain, 2024 -- Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder